CU06-1004 (Sac-1004) is an orally active compound that mitigates endothelial dysfunction by inhibiting hyperpermeability and inflammation. It reduces vascular leakage and inflammation in multiple animal models, including diabetic retinopathy, stroke, cancer, and inflammatory bowel disease. CU06-1004 also improves conditions in a CDAA-induced mouse model of NASH and enhances cardiac function [1] [2] [3].
Molecular Weight:
626.82
CAS Number:
[1296734-08-1]
Formula:
C37H54O8
Target:
Others
T82663
* VAT and and shipping costs not included. Errors and price changes excepted
